aczone Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aczone, and what generic alternatives are available?
Aczone is a drug marketed by Abbvie and Almirall and is included in two NDAs. There are three patents protecting this drug and one Paragraph IV challenge.
This drug has twenty-three patent family members in fifteen countries.
The generic ingredient in ACZONE is dapsone. There are eight drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the dapsone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aczone
A generic version of aczone was approved as dapsone by NOSTRUM LABS INC on May 6th, 2016.
Summary for aczone
International Patents: | 23 |
US Patents: | 3 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 151 |
Clinical Trials: | 15 |
Patent Applications: | 2,494 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for aczone |
Drug Sales Revenues: | Drug sales revenues for aczone |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for aczone |
What excipients (inactive ingredients) are in aczone? | aczone excipients list |
DailyMed Link: | aczone at DailyMed |
Recent Clinical Trials for aczone
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Torrent Pharmaceuticals Limited | Phase 3 |
Catawba Research | Phase 3 |
Icahn School of Medicine at Mount Sinai | Phase 4 |
Pharmacology for aczone
Drug Class | Sulfone |
Anatomical Therapeutic Chemical (ATC) Classes for aczone
US Patents and Regulatory Information for aczone
aczone is protected by three US patents.
Patents protecting aczone
Topical dapsone and dapsone/adapalene compositions and methods for use thereof
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Topical dapsone and dapsone/adaplene compositions and methods for use thereof
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Topical dapsone and dapsone/adapalene compositions and methods for use thereof
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TOPICAL TREATMENT OF ACNE VULGARIS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | ACZONE | dapsone | GEL;TOPICAL | 021794-001 | Jul 7, 2005 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Almirall | ACZONE | dapsone | GEL;TOPICAL | 207154-001 | Feb 24, 2016 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Almirall | ACZONE | dapsone | GEL;TOPICAL | 207154-001 | Feb 24, 2016 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Almirall | ACZONE | dapsone | GEL;TOPICAL | 207154-001 | Feb 24, 2016 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for aczone
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Almirall | ACZONE | dapsone | GEL;TOPICAL | 207154-001 | Feb 24, 2016 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | ACZONE | dapsone | GEL;TOPICAL | 021794-001 | Jul 7, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | ACZONE | dapsone | GEL;TOPICAL | 021794-001 | Jul 7, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
Almirall | ACZONE | dapsone | GEL;TOPICAL | 207154-001 | Feb 24, 2016 | ⤷ Try a Trial | ⤷ Try a Trial |
Almirall | ACZONE | dapsone | GEL;TOPICAL | 207154-001 | Feb 24, 2016 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | ACZONE | dapsone | GEL;TOPICAL | 021794-001 | Jul 7, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for aczone
See the table below for patents covering aczone around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hong Kong | 1072010 | ⤷ Try a Trial | |
Mexico | PA02006593 | DAPSONA TOPICA PARA TRATAMIENTO DEL ACNE. (TOPICAL DAPSONE FOR THE TREATMENT OF ACNE.) | ⤷ Try a Trial |
Japan | 2016500072 | 局所用ダプソンおよびダプソン/アダパレン組成物、ならびにその使用方法 | ⤷ Try a Trial |
European Patent Office | 2922528 | COMPOSITIONS TOPIQUES DE DAPSONE ET DE DAPSONE/ADAPALÈNE ET LEURS MÉTHODES D'UTILISATION (TOPICAL DAPSONE AND DAPSONE/ADAPALENE COMPOSITIONS AND METHODS FOR USE THEREOF) | ⤷ Try a Trial |
Canada | 2477217 | APPLICATION TOPIQUE DE DAPSONE POUR TRAITER L'ACNE (TOPICAL DAPSONE FOR THE TREATMENT OF ACNE) | ⤷ Try a Trial |
Russian Federation | 2638815 | КОМПОЗИЦИИ ДЛЯ МЕСТНОГО ПРИМЕНЕНИЯ, СОДЕРЖАЩИЕ ДАПСОН И ДАПСОН/АДАПАЛЕН, И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ (TOPICAL APPLICATION COMPOSITIONS CONTAINING DAPSON AND DAPSONE/ADAPALEN, AND METHODS FOR THEIR APPLICATION) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |